Story display


ID:

718

Date:

2013-04-15

Headline:

FDA Let Drugs Approved on Faulty Research Stay on the Market

Reporter's name:

Rob Garver and Charles Seife

Delay/denial:

No

Lawsuit:

No

Fees:

No

Media outlet:

ProPublica

City:

Houston, TX

Summary:

After the Food and Drug Administration (FDA) concluded that four-plus years of tests on drugs were unreliable, the FDA made minimal public disclosures or warnings, withdrew no medicine from shelves, and has only finished reviewing about 40% of the replacement studies performed.

Keywords:

Cetero Research, Cetero, drug, pharmaceutical, laboratory, violation, inspection, chemotherapy, prescription, ibuprofen, medication, European Medicines Agency, EMA, confidential commercial information, Center for Drug Evaluation and Research, Food and Drug Administration, FDA, whistleblower

URL:

http://www.propublica.org/article/fda-let-drugs-approved-on-fraudulent-research-stay-on-the-market


Agencies:

FDA

States:

TX

Categories:

business
drug safety
health care


Return to front page